TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in echocardiographic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in serum levels of pro brain natriuretic peptide (pro-BNP) and cardiac troponins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent of Enrolled Participants Retained at Post-intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Attendance Rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: GCase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological complete response (PCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration curve from administration to last observed concentration at time t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in amount of overall opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge from ED/hospital within 7 hours
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Intracardiac electrical characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: tpCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Global Fine Lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Overall Hyperpigmentation/ Discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Global Wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Speech Intelligibility Score on a Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vowel Space Area (kHz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speaking Rate (syl/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophageal motility response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Functional Capacity - Six Minute Walking Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events in healthy volunteers
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events in patients with ILD or CKD
Endpoint domain: Adverse events/effects
Primary endpoint: Healing evaluation in MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric volume measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: local recurrence rate of tumor
Endpoint domain: Mortality/survival
Primary endpoint: Change in global pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline of Count Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Estimate blood levels of sabirnetug (ACU193)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimate time to reach maximum blood levels of sabirnetug (ACU193)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimate time to reach half-life blood levels of sabirnetug (ACU193)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time for bowel sounds to return
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: time to defecate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum Intraocular Pressure Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASH - Disability of the Arm, Shoulder, and Hand
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ROM - range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cannulation pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of facial pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Severity of facial pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vasovagal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of patent dialyzer fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DRSS improvement ≥2 steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in best corrected visual acuity (BCVA) with contrast level of 100% at Month 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in BCVA with contrast level of 10% at Month 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in contrast sensitivity with glare light at Month 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median weekly number of cluster headache attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acylated ghrelin area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Patient Health Questionnaire - 9 Item
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in General Anxiety Disorder - 7 Item
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Post-Traumatic Stress Disorder Checklist - 20 Item
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with moderate or severe Low Back Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of OCS use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participants achieving ≥75% improvement in EAS175
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAND 36 change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Unplanned Hospital Admissions From the ED
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Avoidable Emergency Department (ED) Admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Continuity of Care as Assessed by the Breslau Usual Provider of Care Measure
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Changes in the Revised Physical and Neurological Examination of Subtle Signs (PANESS - Gaits and Stations Measures)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Changes in the Nine-Hole Peg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Motor Control Test Measurements (Posturography)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Medication non-adherence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grading on Mobile Application Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breast MRI radiomics characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain imaging features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers of patients with obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical classification of patients with obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores from the CDS questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Scores from the Niigata PPPD questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in Mean Monthly Migraine Treatment Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of intra-operative cerebral microemboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transitional Angular Displacement of Segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: histological features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gene/protein expression of cartilage and bone biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EASI-75 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: EASI-90 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: IGA Response of Clear or Almost Clear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Walking Speed (Device Off)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of arterial blood gases per participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of unscheduled arterial blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of instances of unreliable transcutaneous monitoring requiring arterial blood gas sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Anatomic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Opioid disposal compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean Relative Reduction From Baseline in Liver Fat Content (LFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Discontinued Study Intervention Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with endoscopic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change on Timed Up and Go - Test 3 Meters (TUG-Test 3M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance (timed up and go test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Socket Comfort Score (SCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehensive Lower-limb Amputee Socket Survey (CLASS) Stability Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehensive Lower-limb Amputee Socket Survey (CLASS) Comfort Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: histopathological pattern diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from Reoperation or Transcatheter Reintervention for Mitral Regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 1-Class Reduction in NYHA Functional Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in CAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of contrast spread in the anteroposterior plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Mayer assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Motor Activity Log (MAL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the number of asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in severity of asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in oppositional defiant disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in impairment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average Self-Measured Morning Home Systolic Blood Pressure (AM H-SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Western Ontario and McMaster University Osteoarthritis index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean Sulcus Bleeding Index (MSBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Il-17 and Il-18 GCF measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hypertension in pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Changes in SCORAD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Ipsilateral breast tumour recurrence
Endpoint domain: Mortality/survival
Primary endpoint: non-response to corticosteroid therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in spherical equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and Specificity of PGx testing for pain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of recurrent ischemic stroke, systemic embolism, or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Overall Performance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oculomotor Metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: UCLA Loneliness Scale Version 3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy Questionnaire for Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Best Friend Index
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Parent-Child Relationship Quality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in 24-h ambulatory systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of MAE within 3 months post-procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Eye Fixations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Scanning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupil Dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment-related Adverse Events (TRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Immune-related adverse events (irAE)
Endpoint domain: Adverse events/effects
Primary endpoint: DNA methylation of catecholamine-degrading enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Awareness of Injury Prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Soy milk consumption effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of urinary leakage episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical improvement of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postpartum pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate at 12 months after HIFU intervention
Endpoint domain: Mortality/survival
Primary endpoint: Weight in grams
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of reversible ischemic injury of brain tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Comparison of ultrasound and elastography values with biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transplacental transfer ratio of maternal anti-virus antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of foreign body giant cells (FBGC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects who successfully completed the setup of the NVHO device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects who successfully completed NVHO self-imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kansas City Cardiomyopathy Questionnaire (KCCQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite Number of: Death, Nonfatal Myocardial infarction (MI), Stroke, and Hospitalization for HF
Endpoint domain: Mortality/survival
Primary endpoint: Reversal of clinical phenotype of VEXAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-6 Cutoff for Severe Sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: LARS Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Formmer's scores of surgical field quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total score of the proxy HRQoL questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Low Back Activity Confidence Scale (LoBACS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Waddell Disability Index (WDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average daily Numeric Pain Rating Scale (NPRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of an adverse event (AE)/ adverse drug reaction (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of a serious AE (SAE)/ serious ADR (SADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of an unexpected AE (UAE)/ unexpected ADR (UADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of a serious unexpected AE (SUAE)/ serious unexpected ADR (SUADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of an adverse event special interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of Granisetron vs Ondansetron for vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total FI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hospitalization or death due to COVID-19 infection
Endpoint domain: Mortality/survival
Primary endpoint: Psoriasis Area Severity Index 90 (PASI90) response at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator´s Global Assessment (IGA) 0/1 response at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-height z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication of gut colonizing antibiotic-resistant bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: intraoperative lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Net Adverse Cardiovascular and Cerebrovascular Events (NACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Magnitude of the Nociceptive Withdrawal Reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apnea-Hypopnea Index (AHI) 4% Events Per Hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Implants survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with prosthesis failure
Endpoint domain: Adverse events/effects
Primary endpoint: Behavioral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetic Retinopathy Disease Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Practicality of gastric ultrasound
Endpoint domain: Delivery of care
Primary endpoint: Usability of gastric ultrasound
Endpoint domain: Delivery of care
Primary endpoint: Acceptability perceived by patients
Endpoint domain: Emotional functioning/wellbeing
Primary endpoint: Demand for gastric ultrasound
Endpoint domain: Resource use
Primary endpoint: Nurses accuracy and confidence
Endpoint domain: Delivery of care
Primary endpoint: Acceptability perceived by nurses
Endpoint domain: Emotional functioning/wellbeing
Primary endpoint: Mortality 28 days after admission
Endpoint domain: Mortality/survival
Primary endpoint: Isometric Elbow Flexion Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes